biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > The xB3 Patents

<< Previous

Bullboard Posts

Next >>

Post by Boomskidon Jun 21, 2023 3:23pm

137 Views

Post# 35507760

The xB3 Patents

Will the xB3 patents soon be owned by an anonymous company out of the Cayman Islands or somewhere else offshore?

Did you notice that there were offshore players among the placees in the recent Biodexa SEC filings about their recent LT financing?

Will the owners of the xB3 patents be anonymous so the Rathjen/LT/Midatech/placees activities won't be easily identified for a year or two, or three?

Will the patents be licensed to another private company, the vehicle that will eventually go for an IPO on NASDAQ?

xB3 will surface again. Different name, obscure players, but we'll know.

jd

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market